BMRA - Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica | Benzinga
- Mr. Kenny has significant executive experience and a proven track record in medical diagnostics and healthcare
- Mr. Kenny most recently served as CEO of Meridian Bioscience where he successfully built and ultimately managed the sale of the company for $1.53 billion
IRVINE, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ:BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, today announced the appointment of Jack Kenny, former CEO and board member of Meridian Bioscience, Inc., to serve as the Chairman of the Board of Directors of Biomerica. Mr. Zack Irani will continue to serve as CEO. Mr. Kenny joined the Biomerica Board of Directors in August 2023 as an independent director.
Most recently Mr. Kenny served as the CEO and executive board member at Meridian Biosciences (formerly traded on Nasdaq under VIVO), which was acquired on January 31, 2023 by SD Biosensor, Inc. and SJL Partners LLC in an all-cash transaction valued at approximately $1.53 billion. Meridian continues to be a leading global provider of diagnostic testing solutions. Meridian's primary focus was gastroenterology products including H. Pylori where the company was a leading manufacturer of the products in the space.
"I'm excited to work more closely with Zack to help refine the company's execution strategies for its exciting new inFoods® IBS product and ...